Jason Hannon Net Worth

The estimated Net Worth of Jason Hannon is at least $7 Million dollars as of 7 March 2017. Mr. Hannon owns over 97,375 units of Orthofix Medical Inc stock worth over $2,476,646 and over the last 19 years he sold OFIX stock worth over $4,526,386. In addition, he makes $0 as Independent Director at Orthofix Medical Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr. Hannon OFIX stock SEC Form 4 insiders trading

Jason has made over 65 trades of the Orthofix Medical Inc stock since 2006, according to the Form 4 filled with the SEC. Most recently he exercised 97,375 units of OFIX stock worth $3,390,598 on 7 March 2017.

The largest trade he's ever made was exercising 97,375 units of Orthofix Medical Inc stock on 7 March 2017 worth over $3,390,598. On average, Jason trades about 7,499 units every 44 days since 2005. As of 7 March 2017 he still owns at least 142,336 units of Orthofix Medical Inc stock.

You can see the complete history of Mr. Hannon stock trades at the bottom of the page.

Jason Hannon biography

Jason M. Hannon serves as Independent Director of the Company. He currently serves as Chief Executive Officer and as a Director of Mainstay Medical International plc, a global medical device company headquartered in Ireland that is focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions. From September 2016 to August 2017, Mr. Hannon served as President and Chief Operating Officer of NuVasive, Inc., a U.S. publicly-traded medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders. Prior to that, Mr. Hannon served during the previous 12 years in various roles of increasing responsibility, including as Executive Vice President, International; Executive Vice President, Corporate Development; and General Counsel. Mr. Hannon has a JD degree from Stanford University Law School and a BA degree from the University of California, Berkeley.

How old is Jason Hannon?

Jason Hannon is 48, he's been the Independent Director of Orthofix Medical Inc since 2020. There are 17 older and no younger executives at Orthofix Medical Inc. The oldest executive at Orthofix Medical Inc is Ronald Matricaria, 77, who is the Independent Chairman of the Board.

What's Jason Hannon's mailing address?

Jason's mailing address filed with the SEC is 3451 PLANO PARKWAY, , LEWISVILLE, TX, 75056.

Insiders trading at Orthofix Medical Inc

Over the last 22 years, insiders at Orthofix Medical Inc have traded over $19,062,472 worth of Orthofix Medical Inc stock and bought 182,076 units worth $5,806,101 . The most active insiders traders include Stuart Essig, Charles R. Kummeth, and Alexis V Lukianov. On average, Orthofix Medical Inc executives and independent directors trade stock every 53 days with the average trade being worth of $179,237. The most recent stock trade was executed by Kevin J. Kenny on 8 January 2024, trading 5,959 units of OFIX stock currently worth $103,687.

What does Orthofix Medical Inc do?

orthofix international began in a small farmhouse in verona italy in 1980 when orthopedic researcher giovanni de bastiani recognized the bone’s natural repair capability, a concept he called “dynamization” and with that in mind, he created the first external fixation device. today, orthofix has grown to more than 900 employees with locations in the u.s., italy, germany, france, the uk, brazil, australia and puerto rico. our products help patients in 70 countries around the world. the company is comprised of four strategic business units; biostim, biologics, extremity fixation and spine fixation. our products are widely distributed via the company's sales representatives, distributors and subsidiaries. at orthofix we are committed to clinical research and driven by new product introductions. we are proud of our strong partnerships with organizations such as the texas scottish rite hospital for children in dallas and the musculoskeletal transplant foundation. we take pride in developing

Complete history of Mr. Hannon stock trades at Nuvasive Inc and Orthofix Medical Inc

Orthofix Medical Inc executives and stock owners

Orthofix Medical Inc executives and other stock owners filed with the SEC include:

• Jon Serbousek,
  President, Chief Executive Officer, Director
• Douglas Rice,
  Chief Financial Officer
• Kimberley Elting,
  Chief Legal and Administrative Officer
• Jon C. Serbousek,
  Pres, CEO & Director
• Kevin J. Kenny,
  Pres of Global Spine Bus.
• Douglas C. Rice,
  CFO & Chief Accounting Officer
• Kimberley A. Elting,
  Chief Legal & Devel. Officer
• Ronald Matricaria,
  Independent Chairman of the Board
• Paul W. Gonsalves,
  Pres of Global Orthofix Orthopedics
• Michael Paolucci,
  Independent Director
• James Hinrichs,
  Independent Director
• Alexis Lukianov,
  Independent Director
• Maria Sainz,
  Independent Director
• Lilly Marks,
  Independent Director
• John Sicard,
  Independent Director
• Paul Gonsalves,
  President of the Orthofix Global Extremities
• Jason Hannon,
  Independent Director
• Kevin Kenny,
  President, Global Orthofix Spine
• Suzanne Armstrong,
  VP of HR
• Jill Mason,
  Chief Ethics & Compliance Officer
• Dan E. Yarbrough,
  VP of Investor Relations
• Tim McGuire,
  Chief Information Officer
• Dr. James T. Ryaby B.A., Ph.D., Chemistry,
  Chief Scientific Officer
• Roberto Donadello,
  Sr. VP, Global Operations
• Michael Finegan,
  
• Robert Allen Ii Goodwin,
  President Biologics
• Rice Doug,
  CFO
• Raymond Fujikawa,
  President Spine Fixation
• Davide Bianchi,
  President, Global Extremities
• Guy J Jordan,
  Director
• Anthony Francis Martin,
  Director
• Luke T Faulstick,
  Director
• Bradley V. Niemann,
  President of Global Spine
• Jeffrey Schumm,
  SVP,General Counsel
• Charles R. Kummeth,
  
• John J. Bostjancic,
  CFO
• Keith Valentine,
  President & CEO
• John B Iii Henneman,
  
• Patrick L Keran,
  Chief Legal Officer
• Stuart Essig,
  Director
• Brad Mason,
  CEO
• Massimo Calafiore,
  President & CEO
• Eric M Brown,
  Sr.V.P. of Sales and Marketing
• De Paul Alberto C Dabreu,
  Director
• John W Littlechild,
  Director
• Cooper Robert Gaines,
  Chairman
• Davey Scoon,
  Director
• Emily Buxton,
  Int. Chief Financial Officer
• James Gero,
  Director
• Wartburg Walter P Von,
  Director
• Randy H Thurman,
  Director
• Mark A Heggestad,
  Chief Financial Officer
• Michael Mainelli,
  Director
• Scott Dodson,
  President, Orthopedics
• Kenneth R Weisshaar,
  Director
• Kathleen T Regan,
  Director
• Thomas M Hein,
  Chief Financial Officer
• Gary Henley,
  President, Americas Division
• Peter J Hewett,
  Director
• Oliver Burckhardt,
  President, International Div
• Alan Milinazzo,
  Chief Operating Officer
• Galvin Mould,
  President, International Div
• Frederik Hartsuiker,
  Director
• Edgar Wallner,
  Deputy Chairman
• Peter Clarke,
  Executive Vice President
• Robert S Vaters,
  Chief Financial Officer
• Stefan Widensohler,
  Director
• Thomas J Kester,
  Director
• Timothy M Adams,
  Chief Financial Officer
• Charles Federico,
  President & CEO
• Vicente Trelles,
  SVP-Worldwide Operations
• Eric Brown,
  President, Spinal Stimulation
• Michael Simpson,
  President, Orthofix Inc.
• Bradley R Mason,
  President of Breg
• Brian Mc Collum,
  Interim CFO
• Jerry Benjamin,
  Director
• Raymond C Kolls,
  VP & General Counsel
• Bryan Mcmillan,
  President, Spine GBU
• Brad Lee,
  President, Breg
• Luigi Ferrari,
  President, Int'l Fixation
• Shweta Maniar,
  
• Julie Andrews,
  CFO
• Patrick Fisher,
  President, Global Orthopedics
• Jorge Andres Cedron,
  CLO
• Wayne Burris,
  
• Thomas A. West,
  Director
• Puja Leekha,
  CECO & Interim CLO
• Geoffrey C Gillespie,
  CAO
• Catherine M Burzik,
  
• Alan Lee Bazaar,
  
• Max Reinhardt,
  President, Global Spine